Drug Discovery and Development |
Avoiding costly missteps in drug development requires well-validated biomarkers that play a critical role in every stage, from initial identification of candidate drug, translational research, clinical development, and reverse translational studies. NanoString’s platforms facilitate efficient biomarker discovery and validation throughout all stages. Whether you require bulk, single-cell or sub-cellular spatial analysis, their innovative technologies can accelerate your discoveries in drug development. |
Accelerate and De-risk Biomarker Discovery and Drug Development |
nCounter® Pro Analysis SystemUp to 800-plex Pathway Based Gene Expression Tissues, FFPE, Biofluids |
GeoMx® Digital Spatial ProfilerMorphological, spatial context for whole transcriptome and proteomics experiments from a single slide |
CosMx™ Spatial Molecular ImagerSingle cell profiling of RNA and proteins with subcellular resolution |